HOTH — Hoth Therapeutics Balance Sheet
0.000.00%
- $4.02m
- -$3.54m
- 14
- 49
- 31
- 22
Annual balance sheet for Hoth Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Short Term Investments | |||||
Cash and Short Term Investments | 2.49 | 4.69 | 10.4 | 6.64 | 9.29 |
Net Total Receivables | — | — | 0.05 | 0 | — |
Prepaid Expenses | |||||
Total Other Current Assets | |||||
Total Current Assets | 2.64 | 4.78 | 10.6 | 6.73 | 9.43 |
Net Property, Plant And Equipment | 0.001 | 0 | — | — | 0.055 |
Long Term Investments | |||||
Long Term Notes Receivable | |||||
Other Long Term Assets | |||||
Total Assets | 2.84 | 5.24 | 11 | 6.76 | 9.52 |
Accounts Payable | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Current Liabilities | 0.44 | 0.312 | 0.868 | 1.39 | 0.679 |
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 0.44 | 0.597 | 1.1 | 1.64 | 0.705 |
Redeemable Preferred Stock | |||||
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | 2.4 | 4.65 | 9.88 | 5.12 | 8.82 |
Total Liabilities & Shareholders' Equity | 2.84 | 5.24 | 11 | 6.76 | 9.52 |
Total Common Shares Outstanding |